Source: Genetics and Molecular Biology. Unidade: HRAC
Subjects: INSUFICIÊNCIA VELOFARÍNGEA, DELEÇÃO DE GENES, FLUORESCÊNCIA
ABNT
SANDRIN-GARCIA, Paula et al. Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies. Genetics and Molecular Biology, v. 30, n. 1, p. 21-24, 2007Tradução . . Disponível em: https://doi.org/10.1590/s1415-47572007000100006. Acesso em: 20 ago. 2024.APA
Sandrin-Garcia, P., Richieri-Costa, A., Tajara, E. H., Carvalho-Salles, A. B., & Fett-Conte, A. C. (2007). Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies. Genetics and Molecular Biology, 30( 1), 21-24. doi:10.1590/s1415-47572007000100006NLM
Sandrin-Garcia P, Richieri-Costa A, Tajara EH, Carvalho-Salles AB, Fett-Conte AC. Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies [Internet]. Genetics and Molecular Biology. 2007 ; 30( 1): 21-24.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1590/s1415-47572007000100006Vancouver
Sandrin-Garcia P, Richieri-Costa A, Tajara EH, Carvalho-Salles AB, Fett-Conte AC. Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies [Internet]. Genetics and Molecular Biology. 2007 ; 30( 1): 21-24.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1590/s1415-47572007000100006